The hedge fund, named the Pfizer Breakthrough Growth Initiative, seeks to pursue new partnerships by funding biotech companies’ research, manufacturing and growth.
Pfizer’s chief business officer, John Young, noted the need to invest in new therapies amid the pandemic. “There has never been a more important moment to pursue new collaborations in our industry,” he said in the press release.
More articles on pharmacy:
5 recent CMS pharmacy policy changes
Eli Lilly testing COVID-19 drug derived from survivor blood
Some pandemic-inspired FDA changes will stick, commissioner says
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.